Who owns Quell Therapeutics?

Quell Therapeutics is currently owned by Jeito Capital, through Jeito I, since 2021.

When did Jeito Capital acquire Quell Therapeutics?

Jeito Capital acquired Quell Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Quell Therapeutics

Quell Therapeutics

Biotech·

United Kingdom·Active·5yr hold

Quell Therapeutics is a biotech company, headquartered in United Kingdom.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Jeito Capital

Key facts

HQUnited Kingdom

SectorBiotech

StatusActive

London-based engineered Treg cell therapy biotech developing therapies for autoimmune disease and transplant rejection; Jeito Capital…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings